Table II.
Clinicopathological data of samples from patients with cervical cancer.
| Sample no. | Age | BMI | CA stage | HPV genotype | Pathology information |
|---|---|---|---|---|---|
| C1 | 38 | 19.63 | IB1 | Negative | Adenocarcinoma in situ |
| C2 | 41 | 21.23 | IB1 | 18 | Adenocarcinoma |
| C3 | 44 | 26.37 | IB1 | 33 | Non-keratinizing squamous cell carcinoma, moderately differentiated, metastasis |
| C4 | 55 | 25.89 | IB1 | 16 | Keratinizing squamous cell carcinoma |
| C5 | 57 | 24.89 | IB2 | 53 | Keratinizing squamous cell carcinoma, poorly differentiated |
| C6 | 51 | 22.56 | IIA | 16 | Squamous cell carcinoma |
| C7 | 50 | 21.90 | IIA | 68 | Mucinous adenocarcinoma, moderately-poorly differentiated, metastasis |
| C8 | 56 | 29.50 | IIA1 | Negative | Papillary squamous cell carcinoma |
| C9 | 55 | 25.80 | IIB | Negative | Large cell non-keratinizing squamous cell carcinoma, poorly differentiated |
| C10 | 59 | 29.09 | IIB | 18 | Adenocarcinoma, endocervical like, metastasis |
| C11 | 62 | 27.40 | IIB | 68 | Squamous cell carcinoma |
| C12 | 58 | 28.39 | IIB | 52 | Squamous cell carcinoma, metastasis |
| C13 | 51 | 22.79 | IIB | 59 | Keratinizing squamous cell carcinoma |
| C14 | 54 | 21.80 | IIB | 16 | Endometrioid adenocarcinoma |
| C15 | 33 | 18.67 | IIB | 16 | Large cell keratinizing squamous cell carcinoma |
| C16 | 80 | 22.60 | IIB | 58 | Non-keratinizing squamous cell carcinoma |
| C17 | 60 | 22.09 | IIB | 16 | Squamous cell carcinoma |
| C18 | 64 | 20.53 | IIB | 18 | Non-keratinizing squamous cell carcinoma, moderately-poorly differentiated |
| C19 | 50 | 23.92 | IIB | 33, LR11 | Keratinizing squamous cell carcinoma, moderately differentiated |
| C20 | 62 | 23.51 | IIB | 18 | Squamous cell carcinoma |
| C21 | 64 | 31.23 | IIB | Negative | Endometrial adenocarcinoma, moderately differentiated, metastasis |
| C22 | 61 | 27.04 | IIB | LR 72 | Endocervical adenocarcinoma, poorly differentiated, metastasis |
| C23 | 49 | 23.88 | IIIB | Negative | Carcinoma, malignant neoplasm of exocervix |
| C24 | 50 | 13.28 | IIIB | Negative | Keratinizing squamous cell carcinoma |
| C25 | 42 | 23.21 | IIIB | 16 | Non-keratinizing squamous cell carcinoma, moderately differentiated |
| C26 | 61 | 28.07 | IIIB | 16 | Non-keratinizing squamous cell carcinoma, well-moderately differentiated |
| C27 | 58 | 23.13 | IIIB | 31 | Non-keratinizing squamous cell carcinoma, moderately differentiated, metastasis |
| C28 | 49 | 17.94 | IVA | 52, 33 | Non-keratinizing squamous cell carcinoma, moderately differentiated |
| C29 | 49 | 25.76 | IVB | 18 | Squamous cell carcinoma, poorly differentiated |
| C30 | 59 | 22.98 | IVB | 52 | Non-keratinizing squamous cell carcinoma, moderately differentiated, metastasis |
| C31 | 43 | 18.27 | IVB | 18, 51 | Adenocarcinoma, metastasis |
BMI, body mass index; HPV, human papillomavirus; CA, cancer antigen.